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Abstract 
Anal cancer usually presents with a visible
or palpable tumour. In this case we describe a
54-year  old  man  diagnosed  with  Cancer  of
Unknown  Primary  (CUP)  with  a  single
inguinal node as the only finding. Thorough
examination  failed  to  identify  any  primary
tumour. The patient was treated with lymph
node dissection and not until nearly two years
after initial diagnosis, was the primary tumour
found, and the patient was diagnosed with anal
cancer. The patient was treated with chemora-
diotherapy and 45 months after initial diagno-
sis there is still no sign of relapse. This case
illustrates, that anal cancer can metastasise
before  the  primary  tumour  is  detectable.
Furthermore, it demonstrates the necessity of
thorough clinical follow-up after treatment of
CUP since the primary tumour was found later.
Finally this is a case of a long-term survivor fol-
lowing  treatment  for  metastatic  inguinal
lymph  nodes  from  an  initially  unknown  pri-
mary cancer.
Introduction
Anal cancer is a rare disease accounting for
only about 1.5% of all of the gastrointestinal
cancers.1 Symptoms are often few and include
rectal bleeding, pain and the sensation of a
mass in the anal region, and as many as 20%
of the patients have no symptoms at all.2
Metastatic  Cancer  of  Unknown  Primary
(CUP)  constitutes  a  heterogonous  group  of
metastatic tumours where the primary tumour
cannot be identified despite thorough clinical
examinations. CUP may account for as many
as 3-5% of all cancers.3
We present a case with anal cancer debuting
as CUP with a single lymph node in the right
inguinal region as the only finding. 
Case Report
A 54-year old man presents with an enlarged
lymph node in the right inguinal region. The
patient is formerly healthy and is in a good
clinical condition. There are no other symp-
toms.  Examination  reveals  a  2¥4  cm  large
lymph node in the right inguinal region but no
other  palpable  lymph  nodes  in  any  other
region. Rectal digital examination is normal. A
biopsy is taken and the histology shows highly
differentiated carcinoma cells. The tumour tis-
sue is CK7+ and CK20–, most likely represent-
ing a squamous cell carcinoma, and the pathol-
ogists conclude that it could be either a malig-
nant  transformation  of  an  epithelial  cyst  or
metastasis  from  lung  or  elsewhere.
Cystoscopy, urine cytology, ultrasound of the
abdomen, gastroscopy and anoscopy are per-
formed and do not reveal any primary tumour.
A  colonoscopy  has  been  performed  in
November 2005 and was normal. CT of the tho-
rax and abdomen reveals a 7.5 mm process in
the left lower lobe near the hilus, and a few
enlarged  lymph  nodes  in  the  mediastinum.
Bronchoscopy is macroscopically normal and
biopsies are without malignancy. The CT-scan
is re-evaluated and the small process in the left
lung  is  not  believed  to  be  a  primary  lung
tumour. Thus, at this point there is still no evi-
dence of a primary tumour.
The  patient  is  referred  to  Department  of
Oncology with the diagnosis of CUP. The biop-
sy is revised and the possible options are still
malignant transformation of epithelial inclu-
sion cyst or cystic metastasis from squamous
cell carcinoma. The patient remains in good
clinical condition. A whole-body FDG-PET/CT is
performed  and  shows  a  malignantly-looking
lymph node in the right inguinal region as the
only finding (Figure 1).
Lymph  node  dissection  is  performed  with
the removal of seven lymph nodes from the
right inguinal region and, histologically, only
one of the lymph nodes is malignant. Histology
shows that a metastasis to lymph node seems
more likely than primary cystic carcinoma but
no further diagnosis can be established. Due to
the fact that the operation might not have been
radical the patient is advised to adjuvant radio-
therapy with 2 Gy x 23. The patient, however,
does not wish radiotherapy towards the right
inguinal region in fear of side effects, and the
patient  is  referred  back  to  Department  of
Surgery for clinical follow-up.
Twenty-three months after initial diagnosis,
a control PET/CT reveals a suspicious lesion in
the rectum/anal canal. A biopsy is taken and
the histology shows squamous cell carcinoma
– the same cells as were found in the right
inguinal region. 
The patient is referred back to Department
of Oncology and 3D-transanal ultrasound and
PET/CT  (Figure  2)  reveals  an  anal  cancer
T2N1M0 (though formerly N2 because of the
right  inguinal  lymph  node  metastasis).  The
patient is treated with radiotherapy concomi-
tant  with  cisplatin  and  5-FU.  The  patient  is
advised to elective inguinal irradiation since
the  disease  debuted  in  the  right  inguinal
region, but the patient still refuses inguinal
irradiation because of possible side-effects. 
Eighteen  months  after  completion  of
chemoradiotherapy  for  anal  cancer  there  is
still no sign of relapse. So far the patient has
lived 45 months since initial cancer diagnosis. 
Discussion
Patients with CUP pose a challenge to clini-
cal oncologists. Since the primary tumour is
not known, the treatment cannot be directed
towards one specific cancer disease, and the
prognosis is often poor. The group of patients
with isolated metastatic inguinal lymph nodes
(squamous carcinoma) constitutes a small but
favourable sub-set of the patients with CUP. In
these patients examination towards identify-
ing the primary tumour should include anorec-
tal  examination,  gynaecological  examination
and  probably  also  a  cystoscopy.3 The  recom-
mended  treatment  for  isolated  metastatic
inguinal lymph nodes continues to be inguinal
lymph node dissection with or without adju-
vant  radiotherapy,  and  long-term  survivors
have been reported.4
We have presented a case in which a patient
presented with a single lymph node metastasis
in the right inguinal region as the only finding.
Despite thorough clinical examination includ-
ing  whole-body  PET/CT  the  primary  tumour
was not found. Not until nearly two years later
did the primary tumour appear on a control
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PET/CT.  Normally,  at  the  time  of  diagnosis,
patients with anal cancer present with a palpa-
ble or visible tumour in the anal canal,5 but our
case illustrates that anal cancer can metasta-
sise before the primary tumour becomes large
enough to be identified. 
The case also demonstrates the necessity of
thorough clinical follow-up after completion of
therapy  for  lymph  node  metastases  of
unknown origin, since the primary tumour was
found  in  the  clinical  follow-up  period.  The
extent of this clinical follow-up is debatable but
should probably include a CT of the abdomen
and  thorax  every  six  months.  Furthermore,
anorectal  and  gynaecological  examinations
should be included in the clinical examination
in addition to the CT. These examinations are
inexpensive and easy to perform, and inguinal
lymph nodes are a known predilection site for
the  spread  of  both  anal  cancer  and  some
gynaecological cancers. 
As  mentioned  earlier  in  the  discussion,
adjuvant radiation therapy following inguinal
lymph node dissection is optional in patients
with isolated metastatic inguinal lymph nodes.
The  patient  in  this  report  declined  adjuvant
inguinal irradiation following lymph node dis-
section, and later, when treated for anal can-
cer,  the  patient  also  declined  prophylactic
inguinal irradiation.
According to a multivariate analysis in the
Phase III EORTC-trial6 inguinal node metasta-
sis  is  an  independent  prognostic  factor  for
treatment failure and overall survival in anal
cancer. In most centres patients with anal can-
cer are treated with prophylactic inguinal irra-
diation but the optimal dose of this radiation
has yet to be established. In a large study on
243 patients with anal cancer Papillon et al.7
showed  that  when  sparing  the  inguinal
regions  only  7.4%  of  the  patients  developed
metachronous inguinal node metastases. This
means that with elective inguinal irradiation
as many as 92.6% of the patients are treated
with unnecessary inguinal irradiation leading
to side-effects. As a consequence of this, in our
centre, only patients with confirmed or suspi-
cious  inguinal  lymph  node  metastases  are
treated with inguinal irradiation. The patient
in  this  report  was  advised  to  prophylactic
inguinal  irradiation  since  the  disease  had
debuted in the inguinal region and therefore
the risk of micrometastatic spread would prob-
ably be higher than in other cases. 
In conclusion, this case illustrates, that anal
cancer  can  metastasise  before  the  primary
tumour is detectable. Furthermore it demon-
strates the necessity of thorough clinical fol-
low-up after treatment of CUP since the pri-
mary tumour was found later. Finally, this is a
case of a long-term survivor following treat-
ment  for  isolated  metastatic  inguinal  lymph
nodes.
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Case Report
Figure  1.  PET/CT-scan  showing  a  single
malignantly-looking  lymph  node  in  the
right inguinal region as the only finding.
Figure  2.  PET/CT-scan  revealing  malig-
nant-looking uptake in the anal canal.